This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Article Remove Digital Health Remove Drug Development Related Topics
eCare Health Analytics BioTech Telecare Life Science Healthcare Cybersecurity mHealth Patient Experience Health Technology Public Health More Related Topics >
article thumbnail

Bonus Features – August 7, 2022 – Patients like digital health but have security concerns, healthcare leaders optimistic “seamless” care is coming, and more

Healthcare IT Today

AUGUST 7, 2022

This article will be a weekly roundup of interesting stories, product announcements, new hires, partnerships, research studies, awards, sales, and more. Data platform H1 is teaming with Lokavant , a clinical trial analytics vendor, to help clinical trial teams determine the best sites for trials in an effort to accelerate drug development.

eCare 82
eCare Digital Health Drug Development Healthcare IT 82
article thumbnail

AstraZeneca launches Evinova, a health-tech business to accelerate innovation across the life sciences sector, the delivery of clinical trials and better health outcomes

Digital Health Global

NOVEMBER 20, 2023

–(BUSINESS WIRE)–AstraZeneca today launches Evinova, set to be a leading provider of digital health solutions to better meet the needs of healthcare professionals, regulators and patients. in 2060.

Life Science 88
Life Science Digital Health Drug Development Patient Experience 88
article thumbnail

QuantHealth Announces $15M Series A for its AI Platform That Enhances Success of Clinical Trials

Digital Health Global

AUGUST 30, 2023

QuantHealth bridges these gaps by simulating trials at scale, to expedite, derisk, and optimize drug development. According to a recent Deloitte article , ROI on pharma R&D has steadily declined, reaching 1.2 This decline is happening at a time when the need for efficient drug development has never been greater.

BioTech 88
BioTech Drug Development Life Science Pharmaceuticals 88
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 82,000+ Insiders by signing up for our newsletter

About
Awards
About
Editions
Awards
Editions
Topics
LinkedIn
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024